Recent advances in allogeneic hematopoietic cell transplanta... : Current Opinion in
Hematology Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid …

Allogeneic hematopoietic cell transplantation (HCT) is a curative treatment modality for
select patients with acute myeloid leukemia (AML), functioning as a restorative agent …

Increasing numbers of patients are receiving allogeneic hematopoietic cell transplantation
(HCT) for acute myeloid leukemia (AML). Scientific and clinical advances in supportive care …

Allogeneic hematopoietic stem cell transplant (HSCT) is an established treatment modality
with curative potential for acute myeloid leukemia (AML). There has been a significant rise in …

Allo-HSCT remains the standard of care for high-risk AML. Increased access to transplant,
reduced toxicity and relapse are improving patient outcomes. Further research is needed to …

Allogeneic hematopoietic stem cell transplantation (HSCT) is commonly used to treat acute
myeloid leukemia (AML) because it is potentially curative when other therapies have a low …

As an important treatment for acute myeloid leukemia, allogeneic hematopoietic stem cell
transplantation (allo-HSCT) plays an important role in reducing relapse and improving long …

Allogeneic hematopoietic stem cell transplantation remains an important treatment modality
for patients with acute myeloid leukemia (AML). Recent advances have extended donor …

Allogeneic hematopoietic stem cell transplantation provides the most powerful antileukemic
effect in the treatment of acute myeloid leukemia. Due to its significant morbidity and …

Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment of many
patients with acute myeloid leukemia (AML). Despite extensive study, the appropriate role …